BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12442384)

  • 1. [Precore region mutation in anti-HBe antibody positive asymptomatic healthy carriers].
    Fukuda R
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):189-94. PubMed ID: 12442384
    [No Abstract]   [Full Text] [Related]  

  • 2. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential analyses of the mutations in the core upstream and precore regions of hepatitis B virus genome in anti-HBe positive-carriers developing acute exacerbation.
    Nishizono A; Kohno K; Takita-Sonoda Y; Hiraga M; Terao H; Fujioka T; Nasu M; Mifune K
    J Med Virol; 1997 Nov; 53(3):266-72. PubMed ID: 9365894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
    Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
    J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HBe-Ag and anti-HBe in asymptomatic HBs-Ag carriers and patients with liver disease.
    Shanmugam J; Balakrishnan V; Thomas M; Jayaprakash PA
    Indian J Pathol Microbiol; 1983 Jan; 26(1):1-5. PubMed ID: 6315579
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
    Tsutsumi Y; Kakumu S; Wakita T; Yoshioka K; Ishikawa T
    J Immunol; 1990 Mar; 144(6):2389-93. PubMed ID: 2313098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.
    Zhang K; Imazeki F; Fukai K; Arai M; Kanda T; Mikata R; Yokosuka O
    J Med Virol; 2007 Jun; 79(6):683-93. PubMed ID: 17457922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B virus infection in the school milieu of Kiffa and Selibaby, Mauritania].
    Rui WZ; Lo Baïdy B; N'Diaye M
    Bull Soc Pathol Exot; 1998; 91(3):247-8. PubMed ID: 9773202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
    Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J
    Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
    Loriot MA; Marcellin P; Talbodec N; Guigonis V; Gigou M; Boyer N; Bezeaud A; Erlinger S; Benhamou JP
    Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular and humoral immunity in asymptomatic carriers of the hepatitis B virus].
    Asfandiiarova NS; Fazylova SM; Tkalicheva LI; Dzhavatova LS
    Ter Arkh; 1984; 56(10):47-9. PubMed ID: 6523361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A follow-up study on HBsAg carriers and factors affecting negative-conversion].
    Hong DQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1984 Jan; 18(1):32-4. PubMed ID: 6468123
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of HBe Ag (hepatitis B e antigen) and anti-HBe (anti-hepatitis B e) in asymptomatic HBs Ag carrier mothers and HBV infection in their families.
    Thanuntaseth C; Theppisai U; Chiewsilp P; Mongkolsuk T
    J Med Assoc Thai; 1988 Mar; 71 Suppl 1():98-101. PubMed ID: 3418277
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis B virus genotypes and mutations in asymptomatic carriers].
    Orito E; Mizokami M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():233-7. PubMed ID: 15453321
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevalence of hepatitis Be antigen and anti-HBE in adults in Benin City.
    Abiodun PO; Olomu A; Okolo SN; Obasohan A; Freeman O
    West Afr J Med; 1994; 13(3):171-4. PubMed ID: 7841109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.
    Ferrari C; Penna A; Bertoletti A; Valli A; Antoni AD; Giuberti T; Cavalli A; Petit MA; Fiaccadori F
    J Immunol; 1990 Nov; 145(10):3442-9. PubMed ID: 2230128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
    Chu CM; Chen YC; Tai DI; Liaw YF
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.